Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

July 1963

Volume 107 New Reflections on Monoamine Oxidase Inhibition

Pages 811–1158

    1. EFFECTS OF MONOAMINE OXIDASE INHIBITION ON BIOGENIC AMINE METABOLISM (pages 840–847)

      M. Goldstein and J. M. Musacchio

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13327.x

    2. THE ROLE OF MONOAMINE OXIDASE IN THE RELEASE AND METABOLISM OF NOREPINEPHRINE (pages 848–855)

      Irwin J. Kopin and Julius Axelrod

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13328.x

    3. BIOLOGICAL ESTIMATION OF THE INTENSITY AND DURATION OF ACTION OF MONOAMINE OXIDASE INHIBITORS (pages 865–877)

      Albert J. Plummer and Patricia A. Furness

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13330.x

    4. STRUCTURE-ACTIVITY RELATIONS IN THE PARGYLINE SERIES (pages 891–898)

      Leo R. Swett, W. B. Martin, J. D. Taylor, G. M. Everett, A. A. Wykes and Y. C. Gladish

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13332.x

    5. PHARMACOLOGICAL AND TOXICOLOGICAL PROPERTIES OF 2-METHYL-3-PIPERIDINOPYRAZINE, A NEW ANTIDEPRESSANT (pages 899–913)

      J. A. Gylys, P. M. R. Muccia and M. K. Taylor

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13333.x

    6. INHIBITION OF MONOAMINE OXIDASE BY 2-METHYL-3-PIPERIDINOPYRAZINE (pages 914–923)

      Bernard Dubnick, D. Fay Morgan and George E. Phillips

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13334.x

    7. ON THE MECHANISM OF HYPOTENSIVE EFFECTS OF MAO INHIBITORS (pages 935–944)

      G. L. Gessa, E. Cuenca and E. Costa

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13336.x

    8. SOME ANTAGONISTS OF THE MONOAMINE OXIDASE INHIBITORS (pages 951–957)

      A. Horita

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13338.x

    9. CORRELATION OF HYPOTENSIVE EFFECTS AND URINARY TRYPTAMINE LEVELS DURING PARGYLINE THERAPY (pages 958–965)

      H. H. Orvis, I. G. Tamagna, D. Horwitz and R. Thomas

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13339.x

    10. ESTIMATION OF MONOAMINE OXIDASE ACTIVITY IN MAN: TECHNIQUES AND APPLICATIONS (pages 966–974)

      Robert J. Levine and Albert Sjoerdsma

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13340.x

    11. BIOCHEMICAL AND PRESSOR EFFECTS OF ORAL d, l-DIHYDROXYPHENYLALANINE IN PATIENTS PRETREATED WITH ANTIDEPRESSANT DRUGS (pages 1005–1015)

      Joseph J. Schildkraut, Gerald L. Klerman, Dale G. Friend and Milton Greenblatt

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13344.x

    12. CARDIAC AND RENAL HEMODYNAMIC RESPONSE TO PARGYLINE (pages 1016–1022)

      Albert N. Brest, Gaddo Onesti, Charles Heider and John H. Moyer

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13345.x

    13. LONG-TERM ANTIHYPERTENSIVE EFFECT OF PARGYLINE HCL WITH AND WITHOUT DIURETIC SULFONAMIDES (pages 1023–1031)

      J. Marion Bryant, Natalio Schvartz, Seta Torosdag, Harrison Fertig, Lucian Fletcher Jr., M. Stephen Schwartz and Richard B. F. Quan

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13346.x

    14. A BASIS FOR THE USE OF MONOAMINE OXIDASE INHIBITORS IN ANGINA PECTORIS (pages 1033–1044)

      David Horwitz and Albert Sjoerdsma

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13347.x

    15. QUANTITATIVE ELECTROENCEPHALOGRAPHY IN MAN AS A MEASURE OF CNS STIMULATION (pages 1045–1056)

      Leonide Goldstein, Henry B. Murphree and Carl C. Pfeiffer

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13348.x

    16. ANOMALOUS ACTIONS OF MONOAMINE OXIDASE INHIBITORS (pages 1057–1067)

      Gordon R. Pscheidt

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13349.x

    17. PHARMACOLOGIC STUDIES OF SOME NONHYDRAZINE MAO INHIBITORS (pages 1068–1080)

      G. M. Everett, R. G. Wiegand and F. U. Rinaldi

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13350.x

    18. USE OF PARGYLINE (EUTONYLTM) IN PRIVATE PRACTICE (pages 1090–1106)

      Nathan S. Kline

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13352.x

    19. ANTIDEPRESSANT EFFECTS OF MAO INHIBITORS (pages 1107–1116)

      Edwin Dunlop

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13353.x

    20. SOME ANTIDEPRESSANT DRUGS AND THEIR MECHANISM OF ACTION ON EXCITABLE MEMBRANES (pages 1139–1146)

      L. G. Abood, H. Kimizuka, G. Rogeness and J. H. Biel

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13356.x

    21. EFFECT OF INHIBITORS OF MONOAMINE OXIDASE ON VARIOUS ENZYMES AND ON THE STORAGE OF MONOAMINES (pages 1147–1151)

      K. F. Gey, A. Pletscher and W. Burkard

      Version of Record online: 15 DEC 2006 | DOI: 10.1111/j.1749-6632.1963.tb13357.x

SEARCH

SEARCH BY CITATION